Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:56 pm Sale |
2024-09-30 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,519,971 6.300% |
-298,624 (-16.42%) |
Filing History |
| 2024-09-03 4:18 pm Unchanged |
2024-08-29 | 13D | Artiva Biotherapeutics, Inc. ARTV |
RA Capital Management, L.P. | 9,853,302 40.600% |
0 (Unchanged) |
Filing History |
| 2024-08-01 7:00 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,818,595 7.800% |
1,818,595 (New Position) |
Filing History |
| 2024-08-01 4:18 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
Venrock Healthcare Capital Partners III L.P. | 1,609,569 6.900% |
1,609,569 (New Position) |
Filing History |
| 2024-08-01 4:17 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
5AM Ventures VI L.P. | 2,353,304 10.100% |
2,353,304 (New Position) |
Filing History |
| 2024-07-29 4:29 pm Purchase |
2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV |
RA Capital Management, L.P. | 9,853,302 42.300% |
9,853,302 (New Position) |
Filing History |
| 2024-07-29 4:15 pm Purchase |
2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV |
GC Corp. | 4,567,412 19.600% |
4,567,412 (New Position) |
Filing History |